REGENERON PHARMACEUTICALS, INC. (CAGE 544P9, UEI N3F9MH7E6HD6) recorded 24 award actions and 5.56 billion in obligated value over the last five years. Most funding is concentrated under the Department of the Army and NAICS 325414, while smaller activity appears in Veterans Affairs and preparedness-related awards.
Federal Contractor
REGENERON PHARMACEUTICALS, INC. Federal Contract Obligations (Last 5 Years)
REGENERON PHARMACEUTICALS, INC. has 24 federal award actions in the last five years, with 5.56 billion in obligated funding tied mainly to the Department of the Army.
Totals reflect the provided analysis window and may include negative obligations in deobligation or adjustment actions.
CAGE Code
544P9
UEI
N3F9MH7E6HD6
Total Obligated
5.56 billion
5,560,409,661.66
Award Actions
24
Average Action Value
231,683,735.90
About REGENERON PHARMACEUTICALS, INC. federal contract activity
REGENERON PHARMACEUTICALS, INC. (CAGE 544P9, UEI N3F9MH7E6HD6) recorded $5.56 billion in obligated federal awards across 24 awards over the last 5 years, for an average award value of $231.68 million. The profile is highly concentrated, with most obligated value tied to a small number of large awards.
Agency mix and customer concentration
The DEPT OF THE ARMY accounts for nearly all observed obligated value at $5.57 billion across 8 awards, making it the dominant contracting relationship in the period. Smaller activity appears with the VETERANS AFFAIRS, DEPARTMENT OF and the OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE, the latter showing negative obligated value in the dataset.
Industry profile based on NAICS activity
Award value is concentrated in NAICS 325414, BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING, which aligns with Regeneron’s core biologics profile and captures $5.57 billion across 8 awards. Secondary activity appears in 325412, PHARMACEUTICAL PREPARATION MANUFACTURING, while 541711, RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY, shows negative obligated value over 14 awards, indicating adjustments or deobligations within the period.
Annual contract trend over the analysis window
Annual obligations peak in 2021 at $5.57 billion across 11 awards, followed by a sharp decline in 2023 to $326.48 million. The remaining years show limited or zero net obligations, including negative net value in 2025 and no net obligation in 2024 and 2022, consistent with a highly episodic award pattern.
How to interpret this page
This summary is based on FPDS Query award records for the last 5 years and uses obligated value, award count, agency, NAICS, and annual trend fields as provided. Negative obligated values are presented as recorded and may reflect modifications, deobligations, or other contract adjustments in the underlying data.
Top Agencies
SELECT
agency_id,
agency_name,
total_obligated,
award_count,
formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
SELECT
content__award__purchaserInformation__contractingOfficeAgencyID AS agency_id,
anyHeavy(content__award__purchaserInformation__contractingOfficeAgencyID__name) AS agency_name,
sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
count() AS award_count
FROM fpds.data
WHERE
contract_type = 1
AND content__award__vendor__vendorSiteDetails__entityIdentifiers__cageCode = '544P9'
AND content__award__purchaserInformation__contractingOfficeAgencyID IS NOT NULL
AND content__award__purchaserInformation__contractingOfficeAgencyID != ''
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 5 YEAR
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
GROUP BY agency_id
)
ORDER BY total_obligated DESC
LIMIT 10| Agency ID | Agency Name | Total Obligated | Readable | Award Actions |
|---|---|---|---|---|
| 2100 | DEPT OF THE ARMY | 5,565,000,000.00 | 5.57 billion | 8 |
| 3600 | VETERANS AFFAIRS, DEPARTMENT OF | 642,323.76 | 642.32 thousand | 2 |
| 7505 | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | -5,232,662.10 | -5.23 million | 14 |
Insight
Over the last 5 years, REGENERON PHARMACEUTICALS, INC. received $5.56 billion across 24 awards, with obligations highly concentrated in the Department of the Army. The Army accounts for $5.57 billion across 8 awards, indicating that nearly all reported obligated value is tied to a single agency relationship. The remaining activity is limited to the Department of Veterans Affairs at $642.32 thousand across 2 awards, while the Office of Assistant Secretary for Preparedness and Response shows net negative obligations of $5.23 million across 14 awards, suggesting downward adjustment activity within that account.
Top NAICS
SELECT
naics_code,
naics_name,
total_obligated,
award_count,
formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
SELECT
content__award__productOrServiceInformation__principalNAICSCode AS naics_code,
anyHeavy(content__award__productOrServiceInformation__principalNAICSCode__description) AS naics_name,
sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
count() AS award_count
FROM fpds.data
WHERE
contract_type = 1
AND content__award__vendor__vendorSiteDetails__entityIdentifiers__cageCode = '544P9'
AND content__award__productOrServiceInformation__principalNAICSCode IS NOT NULL
AND content__award__productOrServiceInformation__principalNAICSCode != ''
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 5 YEAR
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
GROUP BY naics_code
)
ORDER BY total_obligated DESC
LIMIT 10| NAICS Code | Description | Total Obligated | Readable | Award Actions |
|---|---|---|---|---|
| 325414 | BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING | 5,565,000,000.00 | 5.57 billion | 8 |
| 325412 | PHARMACEUTICAL PREPARATION MANUFACTURING | 642,323.76 | 642.32 thousand | 2 |
| 541711 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY | -5,232,662.10 | -5.23 million | 14 |
Insight
Over the last 5 years, obligations for REGENERON PHARMACEUTICALS, INC. (CAGE 544P9) are highly concentrated in NAICS 325414, Biological Product (Except Diagnostic) Manufacturing, which accounts for $5.57 billion across 8 awards and effectively represents the full positive obligated total. The remaining NAICS categories are minimal by comparison: NAICS 325412 shows $642.32 thousand across 2 awards, while NAICS 541711 records a net negative obligation of $5.23 million across 14 awards. This distribution indicates a narrow award concentration in biological product manufacturing, with smaller and offsetting activity in pharmaceutical preparation manufacturing and biotechnology R&D.
Annual Trend
SELECT
year,
total_obligated,
award_count,
formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
SELECT
toYear(parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate)) AS year,
sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
count() AS award_count
FROM fpds.data
WHERE
contract_type = 1
AND content__award__vendor__vendorSiteDetails__entityIdentifiers__cageCode = '544P9'
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 5 YEAR
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
GROUP BY year
)
ORDER BY year DESC| Year | Total Obligated | Readable | Award Actions |
|---|---|---|---|
| 2025 | -331,708,160.10 | -331.71 million | 2 |
| 2024 | 0.00 | 0.00 | 2 |
| 2023 | 326,475,498.00 | 326.48 million | 4 |
| 2022 | 0.00 | 0.00 | 5 |
| 2021 | 5,565,642,323.76 | 5.57 billion | 11 |
Insight
REGENERON PHARMACEUTICALS, INC. (CAGE 544P9) obligates 5.56 billion across 24 awards over the last 5 years, with activity highly concentrated in 2021. That year accounts for 5.57 billion across 11 awards, while 2023 adds 326.48 million across 4 awards. The remaining years are minimal or zero in obligated value, including 2024 at 0.00 and 2022 at 0.00, with 2025 showing a negative obligated amount of 331.71 million across 2 awards, indicating downward adjustment or deobligation activity in the most recent period.
Use FPDS Query for deeper contractor analysis
Explore federal procurement data with custom SQL, fast filtering, and deeper contractor analysis across buying agencies, NAICS, and annual trends.
Continue from this last 5 years view into full FPDS Query workflows with deeper filtering, custom SQL, saved queries, and broader market comparison.